| P50 | author | Edward B Brown | Q73199413 |
| | Danielle S W Benoit | Q79920245 |
| P2093 | author name string | Amy H Van Hove | |
| | Erin Antonienko | |
| | Kathleen Burke | |
| P2860 | cites work | Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology | Q41084437 |
| | Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties | Q42044239 |
| | The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures | Q43508669 |
| | Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). | Q44451889 |
| | Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats | Q44923726 |
| | Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice. | Q45186058 |
| | Robust quantification of in vitro angiogenesis through image analysis | Q46431602 |
| | A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin. | Q46815664 |
| | Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice | Q47862437 |
| | MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing | Q48032058 |
| | Angiotensin II-induced phosphorylation of the AT1 receptor from rat brain neurons | Q48622089 |
| | Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. | Q51569295 |
| | Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. | Q51811203 |
| | A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis. | Q53315869 |
| | Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia | Q54982737 |
| | Glycyl-histidyl-lysine interacts with the angiotensin II AT1 receptor | Q70851933 |
| | Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering | Q73172683 |
| | Controlled release of vascular endothelial growth factor by use of collagen hydrogels | Q73519347 |
| | Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method | Q74088408 |
| | In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy | Q74122408 |
| | Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ | Q77928008 |
| | Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2 | Q84609585 |
| | Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors | Q85092542 |
| | NIH Image to ImageJ: 25 years of image analysis | Q23319322 |
| | Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review | Q26799856 |
| | The future of peptide-based drugs | Q28281702 |
| | Regulation of collagen degradation in the rat myocardium after infarction | Q28580063 |
| | Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. | Q30377799 |
| | Determination of protease cleavage site motifs using mixture-based oriented peptide libraries | Q30702360 |
| | Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions | Q30828538 |
| | Effects of VEGF temporal and spatial presentation on angiogenesis. | Q33620964 |
| | Vascularization strategies for tissue engineering | Q33634565 |
| | Bioartificial matrices for therapeutic vascularization | Q33734474 |
| | SPARC (osteonectin/BM-40). | Q33821099 |
| | Degradable hydrogels for spatiotemporal control of mesenchymal stem cells localized at decellularized bone allografts | Q33859464 |
| | The human tri-peptide GHK and tissue remodeling | Q34012904 |
| | Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo | Q34447297 |
| | A Versatile Synthetic Extracellular Matrix Mimic via Thiol-Norbornene Photopolymerization | Q34481188 |
| | Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics | Q34983148 |
| | Effect of pegylation on pharmaceuticals | Q35075776 |
| | Temporal exposure of cryptic collagen epitopes within ischemic muscle during hindlimb reperfusion | Q35085422 |
| | Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides | Q35246152 |
| | Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting | Q35789129 |
| | Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines | Q35789807 |
| | Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies | Q36137701 |
| | SPARC is a source of copper-binding peptides that stimulate angiogenesis | Q36234286 |
| | Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels | Q36418634 |
| | Sequence-specific determination of protein and peptide concentrations by absorbance at 205 nm | Q36949895 |
| | A review on macrophage responses to biomaterials. | Q37155270 |
| | The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing | Q37224988 |
| | In vivo properties of the proangiogenic peptide QK | Q37242381 |
| | Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels | Q37686574 |
| | Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects | Q37795406 |
| | In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging | Q38256959 |
| | Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis. | Q39354239 |
| | TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. | Q39407549 |
| | Cross-linking and degradation of step-growth hydrogels formed by thiol-ene photoclick chemistry. | Q39465688 |
| | Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. | Q40470101 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydrogel | Q898925 |
| P304 | page(s) | 191-201 | |
| P577 | publication date | 2015-09-11 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Enzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo | |
| P478 | volume | 217 | |